A double-blind, randomised, multicenter, fixed-dose study comparing the efficacy of escitalopram (20mg/day) with that of citalopram (40mg/day) in patients with Major Depressive Disorder.
Phase of Trial: Phase IV
Latest Information Update: 22 Jan 2017
At a glance
- Drugs Citalopram; Escitalopram
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 12 Jan 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 16 Jun 2011 New trial record